Oxford-Harrington Rare Disease Centre Announces 2025 Scholars Advancing Promising Treatments

The Oxford-Harrington Rare Disease Centre ('OHC') today announced the recipients of the 2025 Rare Disease Scholar Award, which ...
BMJ

Use of intravenous aminophylline in addition to the standard first-line treatment in children and adolescents with an acute asthma exacerbation: a systematic review and meta ...

Importance The role of intravenous aminophylline in acute asthma in childhood is unclear. Objectives To assess the safety and efficacy of intravenous aminophylline for asthma in children. Methods From ...

Friedreich's Ataxia Market Research and Forecast Report 2025-2035: Gene Therapy and Small-Molecule Innovations Redefine Treatment Paradigms

The global Friedreich’s ataxia market is experiencing notable growth, fueled by advancements in genetic research, enhanced diagnostic technologies, and increased awareness of this rare ...

Little Raffi, 5, was left battling aggressive cancer – his WALK was the only clue something was wrong

MUM Nicky Starkowitz felt like she’d been “hit by a train” when her son Raffi was handed his cancer diagnosis. The only clue ...
BioPharma Dive

A ‘DNA damage repair’ drugmaker raises $115M for cancer treatments

Artios Pharma, which looking for newer targets that, like PARP inhibitors, affect the way tumors fix themselves, said its ...